Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,064 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015-2020.
Chen TY, Hsiao YC, Wu YW, Lin TH, Sheu WH, Lee TL, Hsieh IC, Li YH, Yin WH, Yeh HI, Chen JW, Lin FJ, Wu CC. Chen TY, et al. Among authors: wu yw. J Formos Med Assoc. 2024 Oct 24:S0929-6646(24)00486-8. doi: 10.1016/j.jfma.2024.10.010. Online ahead of print. J Formos Med Assoc. 2024. PMID: 39455400 Free article.
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan.
Yeh YT, Yin WH, Tseng WK, Lin FJ, Yeh HI, Chen JW, Wu YW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Yeh YT, et al. Among authors: wu cc, wu yw. PLoS One. 2017 Oct 26;12(10):e0186861. doi: 10.1371/journal.pone.0186861. eCollection 2017. PLoS One. 2017. PMID: 29073192 Free PMC article.
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
Ho LT, Lin FJ, Tseng WK, Yin WH, Wu YW, Li YH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Ho LT, et al. Among authors: wu cc, wu yw. J Formos Med Assoc. 2018 Sep;117(9):814-824. doi: 10.1016/j.jfma.2018.05.020. Epub 2018 Jun 23. J Formos Med Assoc. 2018. PMID: 29945742 Free article.
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan.
Li YH, Chen JW, Lin TH, Wang YC, Wu CC, Yeh HI, Huang CC, Chang KC, Wu CK, Chen PW, Huang CW, Chen ZC, Chang WT, Huang WC, Wang CY, Lee MY, Chao AC, Fu WR, Tsai LK, Tang SC, Chan HL, Yang YC, Wu YW, Hwang JJ, Lin JL. Li YH, et al. Among authors: wu cc, wu yw, wu ck. J Formos Med Assoc. 2020 Mar;119(3):674-684. doi: 10.1016/j.jfma.2019.04.007. Epub 2019 May 18. J Formos Med Assoc. 2020. PMID: 31113748 Free article. Review.
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment.
Li YH, Tseng WK, Yin WH, Lin FJ, Wu YW, Hsieh IC, Lin TH, Sheu WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Li YH, et al. Among authors: wu cc, wu yw. Sci Rep. 2020 Dec 14;10(1):21835. doi: 10.1038/s41598-020-78828-8. Sci Rep. 2020. PMID: 33318590 Free PMC article. Clinical Trial.
2022 Taiwan lipid guidelines for primary prevention.
Huang PH, Lu YW, Tsai YL, Wu YW, Li HY, Chang HY, Wu CH, Yang CY, Tarng DC, Huang CC, Ho LT, Lin CF, Chien SC, Wu YJ, Yeh HI, Pan WH, Li YH; expert committee for the Taiwan Lipid Guidelines for Primary Prevention. Huang PH, et al. Among authors: wu yj, wu yw, wu ch. J Formos Med Assoc. 2022 Dec;121(12):2393-2407. doi: 10.1016/j.jfma.2022.05.010. Epub 2022 Jun 14. J Formos Med Assoc. 2022. PMID: 35715290 Free article.
The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease.
Cheong KI, Leu HB, Wu CC, Yin WH, Wang JH, Lin TH, Tseng WK, Chang KC, Chu SH, Yeh HI, Chen JW, Wu YW; National Taiwan Biosignature Research Investigators. Cheong KI, et al. Among authors: wu cc, wu yw. J Formos Med Assoc. 2023 Apr;122(4):328-337. doi: 10.1016/j.jfma.2022.11.011. Epub 2022 Dec 7. J Formos Med Assoc. 2023. PMID: 36494313 Free article.
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
Ho LT, Yin WH, Chuang SY, Tseng WK, Wu YW, Hsieh IC, Lin TH, Li YH, Huang LC, Wang KY, Ueng KC, Fang CC, Pan WH, Yeh HI, Wu CC, Chen JW; Taiwanese Secondary Prevention for patients with AtheRosCLErotic disease (T-SPARCLE) Registry Investigators. Ho LT, et al. Among authors: wu cc, wu yw. PLoS One. 2015 Mar 10;10(3):e0116513. doi: 10.1371/journal.pone.0116513. eCollection 2015. PLoS One. 2015. PMID: 25756522 Free PMC article.
1,064 results